BIO-PATH HOLDINGS, INC. (BPTH)
2025-06-30 | ||||
|---|---|---|---|---|
| Research and development | 4,048 | |||
| General and administrative | 514 | |||
| Total operating expenses | 4,562 | |||
| Net operating loss | -4,562 | |||
| Interest expense | 35 | |||
| Total other income (expense) | -35 | |||
| Net loss | -4,597 | |||
| Earnings per share, basic | -0.55 | |||
| Earnings per share, diluted | -0.55 | |||
| Weighted average number of shares outstanding, basic | 8,308,000 | |||
| Weighted average number of shares outstanding, diluted | 8,308,000 | |||